Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds

被引:58
|
作者
Yan, Hong [1 ]
Chen, Jian [1 ]
Peng, Xi [1 ]
机构
[1] Third Mil Med Univ, Inst Burn Res, South West Hosp, State Key Lab Trauma Burns & Combined Injury, Chongqing 400038, Peoples R China
关键词
Burn; Deep partial thickness burn wounds; Granulocyte-macrophage colony-stimulating factor (GM-CSF); Wound healing; INJURY; CELLS; ULCERS; TISSUE; RATS;
D O I
10.1016/j.burns.2012.02.001
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To assess the effects of recombinant human granulocyte/macrophage colony-stimulating factor (rhGM-CSF) hydrogel on the healing of deep partial thickness burn wounds. Methods: Ninety three wounds of 65 burn patients who suffered from a deep partial thickness burn of <5% TBSA and could not heal over 3 weeks were included in this study. The patients were randomly assigned to use rhGM-CSF hydrogel (GC group, n = 32) or hydrogel without rhGM-CSF (control group, n = 33). rhGM-CSF hydrogel or hydrogel without rhGM-CSF was topically applied to the wounds, the dressing was changed once a day. Wound healing time and percentage, wound discharge, periwound inflammation, the positive wound swabs culture count, and adverse drug reactions were observed and compared between two groups. Results: Healing time was 12.2 +/- 5.0 days after the application of rhGM-CSF hydrogel. This was significantly shorter than that of control wounds (15.5 +/- 4.7 days). Healing percentage at 14 days in the rhGM-CSF-treated wounds was 97.5 +/- 7.7%, which was markedly higher than the control (85.9 +/- 6.8%). At 3, 6, 12, 14 day, the GC group was significantly superior to the control group with respect to the score of periwound inflammation, wound purulence and discharge. The positive wound swabs culture count of the GC group on the 7th and 14th day post-treatment was 14 and 4, respectively, which was significantly lower than the control. Conclusion: rhGM-CSF hydrogel promotes the healing process of deep partial thickness burns effectively. No adverse reaction of the drug was observed during the study. (C) 2012 Elsevier Ltd and ISBI. All rights reserved.
引用
收藏
页码:877 / 881
页数:5
相关论文
共 50 条
  • [1] Study of the use of recombinant human granulocyte-macrophage colony-stimulating factor hydrogel externally to treat residual wounds of extensive deep partial-thickness burn
    Lin Yuan
    Chen Minghua
    Ding Feifei
    Wang Runxiu
    Liang Ziqiang
    Meng Chengyue
    Jia Wenbo
    BURNS, 2015, 41 (05) : 1086 - 1091
  • [2] HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    GASSON, JC
    NIMER, SD
    DIPERSIO, JF
    BALDWIN, GC
    WEISBART, RH
    GOLDE, DW
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 178 - 178
  • [3] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PRODUCES FEVER
    PETERS, WP
    SHOGAN, J
    SHPALL, EJ
    JONES, RB
    KIM, CS
    LANCET, 1988, 1 (8591): : 950 - 950
  • [4] CHEMOTACTIC ACTIVITY OF HUMAN RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    WANG, JM
    COLELLA, S
    ALLAVENA, P
    MANTOVANI, A
    IMMUNOLOGY, 1987, 60 (03) : 439 - 444
  • [5] HUMAN RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - A MULTILINEAGE HEMATOPOIETIN
    SIEFF, CA
    EMERSON, SG
    DONAHUE, RE
    NATHAN, DG
    WANG, EA
    WONG, GG
    CLARK, SC
    SCIENCE, 1985, 230 (4730) : 1171 - 1173
  • [6] CHARACTERIZATION OF PURIFIED RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    GASSON, JC
    WEISBART, RH
    TOMONAGA, M
    GOLDE, DW
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 424 - 424
  • [7] Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor
    Armitage, JO
    BLOOD, 1998, 92 (12) : 4491 - 4508
  • [8] Safety of recombinant human granulocyte-macrophage colony-stimulating factor in healing pediatric severe burns
    Chi, Y. F.
    Chai, J. K.
    Luo, H. M.
    Zhang, Q. X.
    Feng, R.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 2735 - 2741
  • [9] Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor
    McNeel, DG
    Schiffman, K
    Disis, ML
    BLOOD, 1999, 93 (08) : 2653 - 2659
  • [10] EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN BURN PATIENTS
    CIOFFI, WG
    BURLESON, DG
    JORDAN, BS
    BECKER, WK
    MCMANUS, WF
    MASON, AD
    PRUITT, BA
    ARCHIVES OF SURGERY, 1991, 126 (01) : 74 - 79